GlaxoSmithKline (GSK) has said its drug sales in China during the July-to-September quarter sank 61% after it was hit by a bribery scandal. Andrew Witty, chief executive at GSK, said it was too early to predict when the business might recover. via Pocket http://www.bbc.co.uk/news/business-24637195#sa-ns_mchannel=rss&ns_source=PublicRSS20-sa
No comments:
Post a Comment